On Jun 29, we issued an updated research report on Bio-Rad Laboratories ... for the Droplet Digital PCR COVID-19 test kit was encouraging. Partnerships and collaborations in the time of the ...

Earlier in January 2021, Bio-Rad received the FDA’s EUA for its COVID RT-PCR assay kit. However, downsides might result from Bio-Rad’s operation in a highly competitive industry, which ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the recent launch of the Vericheck ddPCR™ Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit. The ...

The SARS-CoV-2 Droplet Digital PCR (ddPCR) test runs on Bio-Rad's QX200 and QXDx ddPCR systems. The high sensitivity of the test makes it well suited to screening upper respiratory samples in patients ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements. The ...